Literature DB >> 12560963

The pattern of urinary acylcarnitines determined by electrospray mass spectrometry: a new tool in the diagnosis of diabetes mellitus.

M Möder1, A Kiessling, H Löster, L Brüggemann.   

Abstract

l-Carnitine and its esters are products of intermediary metabolism of organisms. The distribution pattern or the favored excretion of individual acylcarnitines tells something about metabolic diseases. The determination of the urinary acylcarnitine pattern by flow injection analysis (FIA)-electrospray ionization (ESI)-mass spectrometry (MS) is presented. Groups of healthy probands and patients suffering from diabetes mellitus were investigated due to their significant acylcarnitine profile. The statistical analysis of data sets obtained clearly shows a difference in the acylcarnitine pattern of healthy and sick probands. In comparison to the controls, diabetes mellitus patients excrete more long-chain carnitine esters ranging from dodecanoyl to palmitoylcarnitine. Thus, the urinary acylcarnitine pattern determined by ESI-MS can be a useful tool in the diagnosis and therapy monitoring of diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12560963     DOI: 10.1007/s00216-002-1654-7

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  15 in total

1.  Acylcarnitines as markers of exercise-associated fuel partitioning, xenometabolism, and potential signals to muscle afferent neurons.

Authors:  Jie Zhang; Alan R Light; Charles L Hoppel; Caitlin Campbell; Carol J Chandler; Dustin J Burnett; Elaine C Souza; Gretchen A Casazza; Ronald W Hughen; Nancy L Keim; John W Newman; Gary R Hunter; Jose R Fernandez; W Timothy Garvey; Mary-Ellen Harper; Oliver Fiehn; Sean H Adams
Journal:  Exp Physiol       Date:  2016-12-12       Impact factor: 2.969

2.  Mass Spectral Library of Acylcarnitines Derived from Human Urine.

Authors:  Xinjian Yan; Sanford P Markey; Ramesh Marupaka; Qian Dong; Brian T Cooper; Yuri A Mirokhin; William E Wallace; Stephen E Stein
Journal:  Anal Chem       Date:  2020-04-23       Impact factor: 6.986

3.  Elevated Medium-Chain Acylcarnitines Are Associated With Gestational Diabetes Mellitus and Early Progression to Type 2 Diabetes and Induce Pancreatic β-Cell Dysfunction.

Authors:  Battsetseg Batchuluun; Dana Al Rijjal; Kacey J Prentice; Judith A Eversley; Elena Burdett; Haneesha Mohan; Alpana Bhattacharjee; Erica P Gunderson; Ying Liu; Michael B Wheeler
Journal:  Diabetes       Date:  2018-02-07       Impact factor: 9.461

4.  Carnitine revisited: potential use as adjunctive treatment in diabetes.

Authors:  R A Power; M W Hulver; J Y Zhang; J Dubois; R M Marchand; O Ilkayeva; D M Muoio; R L Mynatt
Journal:  Diabetologia       Date:  2007-02-20       Impact factor: 10.122

5.  CoA protects against the deleterious effects of caloric overload in Drosophila.

Authors:  Laura Palanker Musselman; Jill L Fink; Thomas J Baranski
Journal:  J Lipid Res       Date:  2016-01-24       Impact factor: 5.922

6.  Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women.

Authors:  Sean H Adams; Charles L Hoppel; Kerry H Lok; Ling Zhao; Scott W Wong; Paul E Minkler; Daniel H Hwang; John W Newman; W Timothy Garvey
Journal:  J Nutr       Date:  2009-04-15       Impact factor: 4.798

7.  Metabolomics Analysis of Urine Samples from Children after Acetaminophen Overdose.

Authors:  Laura K Schnackenberg; Jinchun Sun; Sudeepa Bhattacharyya; Pritmohinder Gill; Laura P James; Richard D Beger
Journal:  Metabolites       Date:  2017-09-06

8.  Serum lipid alterations identified in chronic hepatitis B, hepatitis B virus-associated cirrhosis and carcinoma patients.

Authors:  Tao Wu; Xiaojiao Zheng; Ming Yang; Aihua Zhao; Meng Li; Tianlu Chen; Jun Panee; Wei Jia; Guang Ji
Journal:  Sci Rep       Date:  2017-02-15       Impact factor: 4.379

9.  Metabolomic Profiling in Individuals with a Failing Kidney Allograft.

Authors:  Roberto Bassi; Monika A Niewczas; Luigi Biancone; Stefania Bussolino; Sai Merugumala; Sara Tezza; Francesca D'Addio; Moufida Ben Nasr; Alessandro Valderrama-Vasquez; Vera Usuelli; Valentina De Zan; Basset El Essawy; Massimo Venturini; Antonio Secchi; Francesco De Cobelli; Alexander Lin; Anil Chandraker; Paolo Fiorina
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

Review 10.  Role of carnitine and its derivatives in the development and management of type 2 diabetes.

Authors:  Judit Bene; Kinga Hadzsiev; Bela Melegh
Journal:  Nutr Diabetes       Date:  2018-03-07       Impact factor: 5.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.